Home › Calculator › MBRX Dividend Calculator 2026
MBRX Dividend DRIP Calculator 2026
266.63% YieldHealthcareMoleculin Biotech, Inc. · NASDAQ
Price: $0.75 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MBRX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your MBRX snowball 📈
$10,000 in MBRX → $4388.27M in 10 years · $265,946,004.28/month
About Moleculin Biotech, Inc. (MBRX) — Dividend Analysis 2026
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Compare MBRX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MBRX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MBRX position with:
🌍 MBRX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MBRX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 266.63% | 263.83% | $26,663 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 226.64% | 223.84% | $22,664 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 213.30% | 210.50% | $21,330 / yr |
| 🇬🇧 UK ISA | 0% | 266.63% | 263.83% | $26,663 / yr |
| 🇬🇧 UK Taxable | 8.75% | 243.30% | 240.50% | $24,330 / yr |
| 🇨🇦 TFSA | 0% | 266.63% | 263.83% | $26,663 / yr |
| 🇨🇦 CA Taxable | 25% | 199.97% | 197.17% | $19,997 / yr |
| 🇦🇺 Super (pension) | 15% | 226.64% | 223.84% | $22,664 / yr |
| 🇦🇺 AU Taxable | 30% | 186.64% | 183.84% | $18,664 / yr |
| 🇩🇪 DE Taxable | 26.375% | 196.31% | 193.51% | $19,631 / yr |
| 🇫🇷 FR Taxable | 30% | 186.64% | 183.84% | $18,664 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MBRX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MBRX Dividend Payment Schedule
MBRX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 MBRX vs Healthcare Benchmarks
How MBRX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MBRX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MBRX Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MBRX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Moleculin Biotech, Inc. (MBRX) is currently trading at $0.75, 100% below its 52-week high. The current dividend yield is 266.63% based on an annual payout of $2.00 per share.
MBRX (Moleculin Biotech, Inc.) — 266.63% Dividend Yield Analysis
Moleculin Biotech, Inc. (MBRX) is a healthcare stock currently trading at $0.75 with a dividend yield of 266.63%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (266.63%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.